The relative increase in ERK1/2 phosphorylation, and also Akt (S473), may relate to feedback activation to overcome suppressed growth signals as previously seen with pharmacological mTORC1 inhibitors in breast cancer (52). This evidence concerns the gene AKT1 and breast cancer.